Brammer Biopharmaceutical's Merger

Brammer Biopharmaceutical raised a round of funding on March 31, 2016. Investors include Brammer Bio.

Brammer Biopharmaceuticals was founded early in 2015 to create a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO) to enable large pharma and biotech clien…

Articles about Brammer Biopharmaceutical's Merger: